KPIC defies new drug pricing plan

Published: 2006-11-21 06:58:00

Updated: 2006-11-21 06:58:00

The Korea Pharmaceutical Industry Cooperative has reaffirmed their intention to oppose a new positive list system, while calling for the government to protect the benefits of small- and medium-sized drug companies.

The KPIC argues that once the price of all generic drugs is to be lowered by 20...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK